Author: Editorial Team
The editorial team from Sphingotec is researching the latest scientific updates and combines it with diagnostic insights from the frontlines.
Using Proenkephalin A 119-159 as a novel biomarker to estimate GFR
In this interview, Prof. Peter Pickkers (Radboud University Medical Center, Nijmegen) highlights the research background on the novel kidney function biomarker Proenkephalin A 119-159, including a new formula for the glomerular filtration rate (GFR) based on this biomarker.
Current applications of precision medicine in intensive care medicine
Patients suffering from one particular disease are often treated with the same drug – independent of their age, gender, origin, or even the underlying disease mechanisms, which can vary greatly among different patients. In the field of personalized medicine, these differences are considered with the aim of providing individualized treatment to help the patient with the best possible outcome.
Personalized medicine: diagnostic methods transform intensive care medicine
Is it possible to find the best-fitting medication for each individual? Find out more about the importance of diagnostics in personalized medicine in our blog post.
Could it be Sepsis?
„Could it be sepsis? The DeutschlandErkenntSepsis campaign highlights the importance of knowing the signs and symptoms of sepsis to reduce preventable deaths from sepsis and improve outcomes for survivors. Read more in our blog post.
POCT: a bed-side solution to a healthcare challenge
Can point-of-care testing be an alternative to conventional laboratory testing? Learn more about the bed-side solution to a health care challenge in our blog post.
The Era of AKI Biomarkers
Acute kidney injury (AKI) is featured by acute deterioration in renal function, defined by changes in serum creatinine (SCr), urine output, or both. As one syndrome, AKI encompasses a wide variety of causes and risk factors, leading to a decline in kidney function or renal damage.